{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:42:53Z","timestamp":1794937373707,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["RCCCDF-Nov21\\100005"],"award-info":[{"award-number":["RCCCDF-Nov21\\100005"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C7893\/A26233"],"award-info":[{"award-number":["C7893\/A26233"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CANTAC721\\100022"],"award-info":[{"award-number":["CANTAC721\\100022"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C11496\/A17786"],"award-info":[{"award-number":["C11496\/A17786"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C416\/A21999"],"award-info":[{"award-number":["C416\/A21999"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["M917"],"award-info":[{"award-number":["M917"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225491\/Z\/22\/Z"],"award-info":[{"award-number":["225491\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013867\/1"],"award-info":[{"award-number":["MR\/N013867\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","award":["BCRF-22-157"],"award-info":[{"award-number":["BCRF-22-157"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Proliferation is a key hallmark of cancer, but whether it differs between evolutionarily distinct clones co-existing within a tumor is unknown. We introduce the Single-cell Proliferation Rate Inference in Non-homogeneous Tumors through Evolutionary Routes (SPRINTER) algorithm that uses single-cell whole-genome DNA sequencing data to enable accurate identification and clone assignment of S- and G2-phase cells, as assessed by generating accurate ground truth data. Applied to a newly generated longitudinal, primary-metastasis-matched dataset of 14,994 non-small cell lung cancer cells, SPRINTER revealed widespread clone proliferation heterogeneity, orthogonally supported by Ki-67 staining, nuclei imaging and clinical imaging. We further demonstrated that high-proliferation clones have increased metastatic seeding potential, increased circulating tumor DNA shedding and clone-specific altered replication timing in proliferation- or metastasis-related genes associated with expression changes. Applied to previously generated datasets of 61,914 breast and ovarian cancer cells, SPRINTER revealed increased single-cell rates of different genomic variants and enrichment of proliferation-related gene amplifications in high-proliferation clones.<\/jats:p>","DOI":"10.1038\/s41588-024-01989-z","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T05:02:10Z","timestamp":1732856530000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Characterizing the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER"],"prefix":"10.1038","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8169-7767","authenticated-orcid":false,"given":"Olivia","family":"Lucas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6777-5279","authenticated-orcid":false,"given":"Sophia","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-4319","authenticated-orcid":false,"given":"Rija","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7753-9421","authenticated-orcid":false,"given":"Abigail","family":"Bunkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0341-7878","authenticated-orcid":false,"given":"Alexander M.","family":"Frankell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-1312","authenticated-orcid":false,"given":"David A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0718-8934","authenticated-orcid":false,"given":"Mark S.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing Kin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-363X","authenticated-orcid":false,"given":"Daniele","family":"Marinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia L.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Hessey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7097-0307","authenticated-orcid":false,"given":"Cristina","family":"Naceur-Lombardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Rowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukhveer Kaur","family":"Purewal-Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9418-292X","authenticated-orcid":false,"given":"Haoran","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6853-7563","authenticated-orcid":false,"given":"Michelle","family":"Dietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Royle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-9599","authenticated-orcid":false,"given":"Samuel","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"TRACERx Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"PEACE Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9537-4045","authenticated-orcid":false,"given":"Nicholas","family":"McGranahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1212-1259","authenticated-orcid":false,"given":"Mariam","family":"Jamal-Hanjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7232-1952","authenticated-orcid":false,"given":"Nnennaya","family":"Kanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-3018","authenticated-orcid":false,"given":"Charles","family":"Swanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5265-7392","authenticated-orcid":false,"given":"Simone","family":"Zaccaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"1989_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan, D. Hallmarks of cancer: new dimensions. Cancer Discov. 12, 31\u201346 (2022).","journal-title":"Cancer Discov."},{"key":"1989_CR2","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/jcp.2003.010777","volume":"57","author":"PJ Van Diest","year":"2004","unstructured":"Van Diest, P. J., van der Wall, E. & Baak, J. P. Prognostic value of proliferation in invasive breast cancer: a review. J. Clin. Pathol. 57, 675\u2013681 (2004).","journal-title":"J. Clin. Pathol."},{"key":"1989_CR3","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.semcancer.2015.02.006","volume":"35","author":"MA Feitelson","year":"2015","unstructured":"Feitelson, M. A. et al. Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Semin. Cancer Biol. 35, S25\u2013S54 (2015).","journal-title":"Semin. Cancer Biol."},{"key":"1989_CR4","doi-asserted-by":"crossref","DOI":"10.1186\/bcr1618","volume":"8","author":"MJ Beresford","year":"2006","unstructured":"Beresford, M. J., Wilson, G. D. & Makris, A. Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res. 8, 216 (2006).","journal-title":"Breast Cancer Res."},{"key":"1989_CR5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1365-2559.2002.01343.x","volume":"40","author":"DC Brown","year":"2002","unstructured":"Brown, D. C. & Gatter, K. C. Ki67 protein: the immaculate deception? Histopathology 40, 2\u201311 (2002).","journal-title":"Histopathology"},{"key":"1989_CR6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1470-2045(10)70295-3","volume":"12","author":"J Cuzick","year":"2011","unstructured":"Cuzick, J. et al. Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study. Lancet Oncol. 12, 245\u2013255 (2011).","journal-title":"Lancet Oncol."},{"key":"1989_CR7","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1158\/1078-0432.CCR-13-0596","volume":"19","author":"II Wistuba","year":"2013","unstructured":"Wistuba, I. I. et al. Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin. Cancer Res. 19, 6261\u20136271 (2013).","journal-title":"Clin. Cancer Res."},{"key":"1989_CR8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.semcancer.2010.09.002","volume":"21","author":"OM Andrisani","year":"2011","unstructured":"Andrisani, O. M., Studach, L. & Merle, P. Gene signatures in hepatocellular carcinoma (HCC). Semin. Cancer Biol. 21, 4\u20139 (2011).","journal-title":"Semin. Cancer Biol."},{"key":"1989_CR9","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10549-010-0814-2","volume":"120","author":"M Knauer","year":"2010","unstructured":"Knauer, M. et al. The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer. Breast Cancer Res. Treat. 120, 655\u2013661 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"1989_CR10","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"S Paik","year":"2004","unstructured":"Paik, S. et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351, 2817\u20132826 (2004).","journal-title":"N. Engl. J. Med."},{"key":"1989_CR11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrc1802","volume":"6","author":"ML Whitfield","year":"2006","unstructured":"Whitfield, M. L., George, L. K., Grant, G. D. & Perou, C. M. Common markers of proliferation. Nat. Rev. Cancer 6, 99\u2013106 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"1989_CR12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymeth.2015.06.021","volume":"85","author":"A Scialdone","year":"2015","unstructured":"Scialdone, A. et al. Computational assignment of cell-cycle stage from single-cell transcriptome data. Methods 85, 54\u201361 (2015).","journal-title":"Methods"},{"key":"1989_CR13","doi-asserted-by":"crossref","first-page":"lqaa016","DOI":"10.1093\/nargab\/lqaa016","volume":"2","author":"N Andor","year":"2020","unstructured":"Andor, N. et al. Joint single cell DNA-seq and RNA-seq of gastric cancer cell lines reveals rules of in vitro evolution. NAR Genom. Bioinform. 2, lqaa016 (2020).","journal-title":"NAR Genom. Bioinform."},{"key":"1989_CR14","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41586-023-05783-5","volume":"616","author":"AM Frankell","year":"2023","unstructured":"Frankell, A. M. et al. The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 616, 525\u2013533 (2023).","journal-title":"Nature"},{"key":"1989_CR15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/s41586-019-1907-7","volume":"578","author":"M Gerstung","year":"2020","unstructured":"Gerstung, M. et al. The evolutionary history of 2,658 cancers. Nature 578, 122\u2013128 (2020).","journal-title":"Nature"},{"key":"1989_CR16","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/j.cell.2021.03.009","volume":"184","author":"SC Dentro","year":"2021","unstructured":"Dentro, S. C. et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. Cell 184, 2239\u20132254 (2021).","journal-title":"Cell"},{"key":"1989_CR17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.cell.2019.10.026","volume":"179","author":"E Laks","year":"2019","unstructured":"Laks, E. et al. Clonal decomposition and DNA replication states defined by scaled single-cell genome sequencing. Cell 179, 1207\u20131221 (2019).","journal-title":"Cell"},{"key":"1989_CR18","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41587-020-0661-6","volume":"39","author":"S Zaccaria","year":"2021","unstructured":"Zaccaria, S. & Raphael, B. J. Characterizing allele- and haplotype-specific copy numbers in single cells with CHISEL. Nat. Biotechnol. 39, 207\u2013214 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1989_CR19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41586-022-05249-0","volume":"612","author":"T Funnell","year":"2022","unstructured":"Funnell, T. et al. Single-cell genomic variation induced by mutational processes in cancer. Nature 612, 106\u2013115 (2022).","journal-title":"Nature"},{"key":"1989_CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41586-021-03357-x","volume":"592","author":"DC Minussi","year":"2021","unstructured":"Minussi, D. C. et al. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature 592, 302\u2013308 (2021).","journal-title":"Nature"},{"key":"1989_CR21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41586-023-05729-x","volume":"616","author":"M Al Bakir","year":"2023","unstructured":"Al Bakir, M. et al. The evolution of non-small cell lung cancer metastases in TRACERx. Nature 616, 534\u2013542 (2023).","journal-title":"Nature"},{"key":"1989_CR22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s41586-018-0409-3","volume":"560","author":"U Ben-David","year":"2018","unstructured":"Ben-David, U. et al. Genetic and transcriptional evolution alters cancer cell line drug response. Nature 560, 325\u2013330 (2018).","journal-title":"Nature"},{"key":"1989_CR23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature12625","volume":"501","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A., McGranahan, N., Bartek, J. & Swanton, C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature 501, 338\u2013345 (2013).","journal-title":"Nature"},{"key":"1989_CR24","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.trecan.2023.03.002","volume":"9","author":"S Hessey","year":"2023","unstructured":"Hessey, S., Fessas, P., Zaccaria, S., Jamal-Hanjani, M. & Swanton, C. Insights into the metastatic cascade through research autopsies. Trends Cancer 9, 490\u2013502 (2023).","journal-title":"Trends Cancer"},{"key":"1989_CR25","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ccell.2022.04.002","volume":"40","author":"O Pich","year":"2022","unstructured":"Pich, O. et al. The translational challenges of precision oncology. Cancer Cell 40, 458\u2013478 (2022).","journal-title":"Cancer Cell"},{"key":"1989_CR26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.aaf2784","volume":"352","author":"S Turajlic","year":"2016","unstructured":"Turajlic, S. & Swanton, C. Metastasis as an evolutionary process. Science 352, 169\u2013175 (2016).","journal-title":"Science"},{"key":"1989_CR27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium.","year":"2020","unstructured":"ICGC\/TCGA Pan-Cancer Analysis of Whole Genomes Consortium. Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"1989_CR28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30212-y","volume":"13","author":"DJ Massey","year":"2022","unstructured":"Massey, D. J. & Koren, A. High-throughput analysis of single human cells reveals the complex nature of DNA replication timing control. Nat. Commun. 13, 2402 (2022).","journal-title":"Nat. Commun."},{"key":"1989_CR29","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nmeth.3578","volume":"12","author":"T Garvin","year":"2015","unstructured":"Garvin, T. et al. Interactive analysis and assessment of single-cell copy-number variations. Nat. Methods 12, 1058\u20131060 (2015).","journal-title":"Nat. Methods"},{"key":"1989_CR30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-020-2698-6","volume":"587","author":"TBK Watkins","year":"2020","unstructured":"Watkins, T. B. K. et al. Pervasive chromosomal instability and karyotype order in tumour evolution. Nature 587, 126\u2013132 (2020).","journal-title":"Nature"},{"key":"1989_CR31","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1038\/s41596-020-0378-5","volume":"15","author":"H Miura","year":"2020","unstructured":"Miura, H. et al. Mapping replication timing domains genome wide in single mammalian cells with single-cell DNA replication sequencing. Nat. Protoc. 15, 4058\u20134100 (2020).","journal-title":"Nat. Protoc."},{"key":"1989_CR32","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446\u2013451 (2017).","journal-title":"Nature"},{"key":"1989_CR33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","volume":"616","author":"C Abbosh","year":"2023","unstructured":"Abbosh, C. et al. Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA. Nature 616, 553\u2013562 (2023).","journal-title":"Nature"},{"key":"1989_CR34","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ccell.2023.04.008","volume":"41","author":"MJM Magbanua","year":"2023","unstructured":"Magbanua, M. J. M. et al. Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy. Cancer Cell 41, 1091\u20131102 (2023).","journal-title":"Cancer Cell"},{"key":"1989_CR35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1101\/gr.099655.109","volume":"20","author":"T Ryba","year":"2010","unstructured":"Ryba, T. et al. Evolutionarily conserved replication timing profiles predict long-range chromatin interactions and distinguish closely related cell types. Genome Res. 20, 761\u2013770 (2010).","journal-title":"Genome Res."},{"key":"1989_CR36","doi-asserted-by":"crossref","first-page":"e1001011","DOI":"10.1371\/journal.pgen.1001011","volume":"6","author":"E Yaffe","year":"2010","unstructured":"Yaffe, E. et al. Comparative analysis of DNA replication timing reveals conserved large-scale chromosomal architecture. PLoS Genet. 6, e1001011 (2010).","journal-title":"PLoS Genet."},{"key":"1989_CR37","doi-asserted-by":"crossref","first-page":"a010132","DOI":"10.1101\/cshperspect.a010132","volume":"5","author":"N Rhind","year":"2013","unstructured":"Rhind, N. & Gilbert, D. M. DNA replication timing. Cold Spring Harb. Perspect. Biol. 5, a010132 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1989_CR38","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-50107-4","volume":"15","author":"M Dietzen","year":"2024","unstructured":"Dietzen, M. et al. Replication timing alterations are associated with mutation acquisition during breast and lung cancer evolution. Nat. Commun. 15, 6039 (2024).","journal-title":"Nat. Commun."},{"key":"1989_CR39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.semcancer.2013.01.001","volume":"23","author":"N Donley","year":"2013","unstructured":"Donley, N. & Thayer, M. J. DNA replication timing, genome stability and cancer: late and\/or delayed DNA replication timing is associated with increased genomic instability. Semin. Cancer Biol. 23, 80\u201389 (2013).","journal-title":"Semin. Cancer Biol."},{"key":"1989_CR40","volume":"10","author":"Q Du","year":"2019","unstructured":"Du, Q. et al. Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer. Nat. Commun. 10, 416 (2019).","journal-title":"Nat. Commun."},{"key":"1989_CR41","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1182\/bloodadvances.2019000641","volume":"3","author":"JC Rivera-Mulia","year":"2019","unstructured":"Rivera-Mulia, J. C. et al. Replication timing alterations in leukemia affect clinically relevant chromosome domains. Blood Adv. 3, 3201\u20133213 (2019).","journal-title":"Blood Adv."},{"key":"1989_CR42","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1101\/gr.138511.112","volume":"22","author":"T Ryba","year":"2012","unstructured":"Ryba, T. et al. Abnormal developmental control of replication-timing domains in pediatric acute lymphoblastic leukemia. Genome Res. 22, 1833\u20131844 (2012).","journal-title":"Genome Res."},{"key":"1989_CR43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.exphem.2017.04.004","volume":"51","author":"T Sasaki","year":"2017","unstructured":"Sasaki, T. et al. Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia. Exp. Hematol. 51, 71\u201382 (2017).","journal-title":"Exp. Hematol."},{"key":"1989_CR44","doi-asserted-by":"crossref","first-page":"D882","DOI":"10.1093\/nar\/gkz1062","volume":"48","author":"Y Luo","year":"2020","unstructured":"Luo, Y. et al. New developments on the Encyclopedia of DNA Elements (ENCODE) data portal. Nucleic Acids Res. 48, D882\u2013D889 (2020).","journal-title":"Nucleic Acids Res."},{"key":"1989_CR45","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nprot.2017.148","volume":"13","author":"C Marchal","year":"2018","unstructured":"Marchal, C. et al. Genome-wide analysis of replication timing by next-generation sequencing with E\/L Repli-seq. Nat. Protoc. 13, 819\u2013839 (2018).","journal-title":"Nat. Protoc."},{"key":"1989_CR46","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","volume":"4","author":"SM Dewhurst","year":"2014","unstructured":"Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175\u2013185 (2014).","journal-title":"Cancer Discov."},{"key":"1989_CR47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41588-020-0584-7","volume":"52","author":"S Lopez","year":"2020","unstructured":"Lopez, S. et al. Interplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution. Nat. Genet. 52, 283\u2013293 (2020).","journal-title":"Nat. Genet."},{"key":"1989_CR48","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41588-018-0106-z","volume":"50","author":"M El-Kebir","year":"2018","unstructured":"El-Kebir, M., Satas, G. & Raphael, B. J. Inferring parsimonious migration histories for metastatic cancers. Nat. Genet. 50, 718\u2013726 (2018).","journal-title":"Nat. Genet."},{"key":"1989_CR49","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.cels.2021.07.006","volume":"12","author":"G Satas","year":"2021","unstructured":"Satas, G., Zaccaria, S., El-Kebir, M. & Raphael, B. J. DeCiFering the elusive cancer cell fraction in tumor heterogeneity and evolution. Cell Syst. 12, 1004\u20131018 (2021).","journal-title":"Cell Syst."},{"key":"1989_CR50","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s43588-022-00298-x","volume":"2","author":"C K\u0131z\u0131lkale","year":"2022","unstructured":"K\u0131z\u0131lkale, C. et al. Fast intratumor heterogeneity inference from single-cell sequencing data. Nat. Comput. Sci. 2, 577\u2013583 (2022).","journal-title":"Nat. Comput. Sci."},{"key":"1989_CR51","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-022-02794-9","volume":"23","author":"TL Kaufmann","year":"2022","unstructured":"Kaufmann, T. L. et al. MEDICC2: whole-genome doubling aware copy-number phylogenies for cancer evolution. Genome Biol. 23, 241 (2022).","journal-title":"Genome Biol."},{"key":"1989_CR52","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41586-023-05706-4","volume":"616","author":"C Martinez-Ruiz","year":"2023","unstructured":"Martinez-Ruiz, C. et al. Genomic-transcriptomic evolution in lung cancer and metastasis. Nature 616, 543\u2013552 (2023).","journal-title":"Nature"},{"key":"1989_CR53","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","volume":"47","author":"LB Alexandrov","year":"2015","unstructured":"Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. Nat. Genet. 47, 1402\u20131407 (2015).","journal-title":"Nat. Genet."},{"key":"1989_CR54","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"1989_CR55","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/s41588-021-00891-2","volume":"53","author":"Y Bollen","year":"2021","unstructured":"Bollen, Y. et al. Reconstructing single-cell karyotype alterations in colorectal cancer identifies punctuated and gradual diversification patterns. Nat. Genet. 53, 1187\u20131195 (2021).","journal-title":"Nat. Genet."},{"key":"1989_CR56","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s41586-022-04789-9","volume":"606","author":"RM Drews","year":"2022","unstructured":"Drews, R. M. et al. A pan-cancer compendium of chromosomal instability. Nature 606, 976\u2013983 (2022).","journal-title":"Nature"},{"key":"1989_CR57","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1016\/j.celrep.2016.02.023","volume":"14","author":"J Campbell","year":"2016","unstructured":"Campbell, J. et al. Large-scale profiling of kinase dependencies in cancer cell lines. Cell Rep. 14, 2490\u20132501 (2016).","journal-title":"Cell Rep."},{"key":"1989_CR58","volume":"6","author":"Z Fan","year":"2017","unstructured":"Fan, Z. et al. Nrf2-Keap1 pathway promotes cell proliferation and diminishes ferroptosis. Oncogenesis 6, e371 (2017).","journal-title":"Oncogenesis"},{"key":"1989_CR59","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","volume":"23","author":"HK Matthews","year":"2022","unstructured":"Matthews, H. K., Bertoli, C. & de Bruin, R. A. M. Cell cycle control in cancer. Nat. Rev. Mol. Cell Biol. 23, 74\u201388 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1989_CR60","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1080\/15384101.2015.1049784","volume":"14","author":"K Kostyrko","year":"2015","unstructured":"Kostyrko, K., Bosshard, S., Urban, Z. & Mermod, N. A role for homologous recombination proteins in cell cycle regulation. Cell Cycle 14, 2853\u20132861 (2015).","journal-title":"Cell Cycle"},{"key":"1989_CR61","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-023-01793-z","volume":"22","author":"A Akhmetkaliyev","year":"2023","unstructured":"Akhmetkaliyev, A., Alibrahim, N., Shafiee, D. & Tulchinsky, E. EMT\/MET plasticity in cancer and Go-or-Grow decisions in quiescence: the two sides of the same coin? Mol. Cancer 22, 90 (2023).","journal-title":"Mol. Cancer"},{"key":"1989_CR62","doi-asserted-by":"crossref","first-page":"4615","DOI":"10.1091\/mbc.e07-05-0406","volume":"18","author":"J Mejlvang","year":"2007","unstructured":"Mejlvang, J. et al. Direct repression of cyclin D1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition. Mol. Biol. Cell 18, 4615\u20134624 (2007).","journal-title":"Mol. Biol. Cell"},{"key":"1989_CR63","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1073\/pnas.1811923116","volume":"116","author":"S Shin","year":"2019","unstructured":"Shin, S. et al. ERK2 regulates epithelial-to-mesenchymal plasticity through DOCK10-dependent Rac1\/FoxO1 activation. Proc. Natl Acad. Sci. USA 116, 2967\u20132976 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1989_CR64","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.294104","volume":"18","author":"S Vega","year":"2004","unstructured":"Vega, S. et al. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev. 18, 1131\u20131143 (2004).","journal-title":"Genes Dev."},{"key":"1989_CR65","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41587-021-01109-w","volume":"40","author":"C Gabbutt","year":"2022","unstructured":"Gabbutt, C. et al. Fluctuating methylation clocks for cell lineage tracing at high temporal resolution in human tissues. Nat. Biotechnol. 40, 720\u2013730 (2022).","journal-title":"Nat. Biotechnol."},{"key":"1989_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30043-x","volume":"13","author":"S Gnan","year":"2022","unstructured":"Gnan, S. et al. Kronos scRT: a uniform framework for single-cell replication timing analysis. Nat. Commun. 13, 2329 (2022).","journal-title":"Nat. Commun."},{"key":"1989_CR67","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-020-02119-8","volume":"21","author":"XF Mallory","year":"2020","unstructured":"Mallory, X. F., Edrisi, M., Navin, N. & Nakhleh, L. Methods for copy number aberration detection from single-cell DNA-sequencing data. Genome Biol. 21, 208 (2020).","journal-title":"Genome Biol."},{"key":"1989_CR68","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"1989_CR69","doi-asserted-by":"crossref","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang, Z., Liu, X. & Peltz, G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics 39, btac757 (2023).","journal-title":"Bioinformatics"},{"key":"1989_CR70","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1989_CR71","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1989_CR72","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","volume":"17","author":"P Virtanen","year":"2020","unstructured":"Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261\u2013272 (2020).","journal-title":"Nat. Methods"},{"key":"1989_CR73","doi-asserted-by":"publisher","unstructured":"Lucas, O., Zaidi, R., Bunkum, A. & Zaccaria, S. Processed data for \u2018Characterising the evolutionary dynamics of cancer proliferation in single-cell clones with SPRINTER\u2019 (v1.0). Zenodo https:\/\/doi.org\/10.5281\/zenodo.13754279 (2024).","DOI":"10.5281\/zenodo.13754279"},{"key":"1989_CR74","doi-asserted-by":"publisher","unstructured":"Williams. Single cell whole genome sequencing from Funnell, O'Flanagan, Williams et al. (0.2). Zenodo https:\/\/doi.org\/10.5281\/zenodo.6998936 (2022).","DOI":"10.5281\/zenodo.6998936"},{"key":"1989_CR75","doi-asserted-by":"publisher","unstructured":"Williams, M. J. HMMcopy result for Funnell et al. Zenodo https:\/\/doi.org\/10.5281\/zenodo.7718917 (2023).","DOI":"10.5281\/zenodo.7718917"},{"key":"1989_CR76","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41592-018-0046-7","volume":"15","author":"B Gruning","year":"2018","unstructured":"Gruning, B. et al. Bioconda: sustainable and comprehensive software distribution for the life sciences. Nat. Methods 15, 475\u2013476 (2018).","journal-title":"Nat. Methods"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01989-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01989-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:03:24Z","timestamp":1778861004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41588-024-01989-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1989"],"URL":"https:\/\/doi.org\/10.1038\/s41588-024-01989-z","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"11 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.M.F. is a co-inventor on a patent application to determine methods and systems for tumor monitoring (PCT\/EP2022\/077987). D.A.M. reports speaker fees from AstraZeneca and Takeda; consultancy fees from AstraZeneca, Thermo Fisher, Takeda, Amgen, Janssen, MIM Software, Bristol Myers Squibb and Eli Lilly and has received educational support from Takeda and Amgen. S.A. is a founder and shareholder of GenomeTherapeutics and scientific advisor to Sangamo Therapeutics, the Institute of Cancer Research, London, and the New York Genome Center, NY. N.M. has stock options in and has consulted for Achilles Therapeutics; holds a European patent in determining HLA LOH (PCT\/GB2018\/052004) and is a co-inventor to a patent to identifying responders to cancer treatment (PCT\/GB2018\/051912). M.J.-H. has received funding from CRUK, the National Institutes of Health (NIH) National Cancer Institute, International Association for the Study of Lung Cancer (IASLC) Foundation, Lung Cancer Research Foundation, Rosetrees Trust, UKI NETs and NIHR; has consulted for Astex Pharmaceutical and Achilles Therapeutics; is a member of the Achilles Therapeutics Scientific Advisory Board and Steering Committee and has received speaker honoraria from Pfizer, Astex Pharmaceuticals, Oslo Cancer Cluster, Bristol Myers Squibb and Genentech. M.J.-H. is listed as a co-inventor on a European patent application relating to methods to detect lung cancer (PCT\/US2017\/028013); this patent has been licensed to commercial entities, and, under terms of employment, M.J.-H. is due a share of any revenue generated from such license(s) and is also listed as a co-inventor on the GB priority patent application (GB2400424.4) with title\u2014Treatment and Prevention of Lung Cancer. C.S. acknowledges grants from AstraZeneca, Boehringer-Ingelheim, Bristol Myers Squibb, Pfizer, Roche-Ventana, Invitae (previously Archer Dx\u2014collaboration in minimal residual disease sequencing technologies), Ono Pharmaceutical and Personalis. He is the chief investigator for the AZ MeRmaiD 1 and 2 clinical trials and is the Steering Committee Chair. He is also the co-chief investigator of the NHS Galleri trial funded by GRAIL and a paid member of GRAIL\u2019s Scientific Advisory Board (SAB). He receives consultant fees from Achilles Therapeutics (also a SAB member), Bicycle Therapeutics (also a SAB member), Genentech, Medicxi, the China Innovation Centre of Roche (CICoR), formerly Roche Innovation Centre\u2014Shanghai, Metabomed (until July 2022), Relay Therapeutics SAB member, Saga Diagnostics SAB member and the Sarah Cannon Research Institute. C.S. has received honoraria from Amgen, AstraZeneca, Bristol Myers Squibb, GlaxoSmithKline, Illumina, MSD, Novartis, Pfizer and Roche-Ventana. C.S. has previously held stock options in Apogen Biotechnologies and GRAIL; currently has stock options in Epic Bioscience, Bicycle Therapeutics and Relay Therapeutics; and has stock options and is cofounder of Achilles Therapeutics. C.S. declares a patent application for methods to lung cancer (PCT\/US2017\/028013), targeting neoantigens (PCT\/EP2016\/059401), identifying patent response to immune checkpoint blockade (PCT\/EP2016\/071471), methods for lung cancer detection (US20190106751A1), identifying patients who respond to cancer treatment (PCT\/GB2018\/051912), determining HLA LOH (PCT\/GB2018\/052004), predicting survival rates of patients with cancer (PCT\/GB2020\/050221), methods and systems for tumor monitoring (PCT\/EP2022\/077987). C.S. is an inventor on a European patent application (PCT\/GB2017\/053289) relating to assay technology to detect tumor recurrence. This patent has been licensed to a commercial entity, and, under their terms of employment, C.S. is due a revenue share of any revenue generated from such license(s). The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}